Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
about
Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in NigeriaA repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodesA randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, IndiaHaiti National Program for the elimination of lymphatic filariasis--a model of success in the face of adversity.Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles.The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.Promoting good clinical laboratory practices and laboratory accreditation to support clinical trials in sub-Saharan Africa.Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi.12-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of bi-annual treatment with ivermectin and albendazole.Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review meta-analysis and individual patient data analysis.Factors Associated with Wuchereria bancrofti Microfilaremia in an Endemic Area of Mali.Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
P2860
Q28477441-D1217384-75C9-415B-8ED4-ABC2A8747AA2Q28539772-C4FBF3F2-113D-44B5-912A-05BDDC7560B8Q28544440-C86CAD5F-327E-4DA4-ACA5-AC6DCBDBFD9AQ29036688-9975D301-E27C-4403-B234-D2B54F457067Q33882905-7DAB6E91-C3C1-4105-924E-F41384297960Q35590790-BF7E6AD4-354C-4A66-913F-7286A636BC7AQ36112241-4EF27825-B45A-4CAF-BA77-5A6F7578E337Q38413227-B7C93DAB-2399-4B1D-AF0D-6609BEF1D179Q40048094-2AAE7514-FA36-479E-826A-6FFA17758572Q42284546-58B55B77-20BF-48A5-B127-AA45FD6D44CBQ52558340-BE1FC1C9-CBB1-4B1B-80E8-7203B6B31CC0Q53687543-D683BC65-6A9C-4D76-9DFF-02BCD32DF018Q54210031-A8DACB78-0A98-41C1-9964-54087A0540CBQ54983273-718AB305-50E3-4A74-BD46-CDFF0EBBAEFB
P2860
Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@ast
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@en
type
label
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@ast
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@en
prefLabel
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@ast
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@en
P2093
P2860
P50
P356
P1476
Use of high-dose, twice-yearly ...... ancrofti microfilarial levels.
@en
P2093
Abdallah A Diallo
Adama Diaman Keita
Benoit Dembele
Dramane Sanogo
Housseini Dolo
Lamine Soumaoro
Salif Seriba Doumbia
Sekou F Traore
Siaka Konate
Siaka Y Coulibaly
P2860
P304
P356
10.1086/657063
P407
P577
2010-11-01T00:00:00Z